V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012719 | 330004291 | 1.6 | null | Palliative (P) | 2017-06-10 | 2018-01-18 | ETOPOSIDE + IFOSFAMIDE | N | N | 330011005 | ETOPOSIDE + IFOSFAMIDE |
| 330012720 | 330004291 | null | 61 | Palliative (P) | 2016-07-10 | 2016-07-10 | PAM x 2 post-surgery (cycles 3&4) | 2 | N | 330011005 | MAP |
| 330012721 | 330008347 | 1.77 | null | Palliative (P) | 2018-01-07 | 2018-01-28 | OST Euramos 1 Closed Trial - M | null | null | 330011029 | METHOTREXATE HIGH DOSE |
| 330012722 | 330004302 | 1.83 | 69 | Curative (C) | 2013-01-13 | 2013-08-28 | OST Euramos 1 Closed Trial - M | 02 | N | 330011097 | METHOTREXATE HIGH DOSE |
| 330012723 | 330004307 | 1.74 | 70.1 | Adjuvant (A) | 2018-05-09 | 2018-06-10 | VAI (Ifos 3g/m2) | 02 | N | 330011197 | VAI |
| 330012725 | 330004328 | 0.9 | 60.9 | Curative (C) | null | 2017-01-31 | VAI (Ifos 3g/m2) | null | null | 330011340 | VAI |
| 330012726 | 330008367 | null | 83.4 | Palliative (P) | 2018-10-15 | 2018-10-15 | CARBOPLATIN + PACLITAXEL | N | N | 330011441 | CARBOPLATIN + PACLITAXEL |
| 330012727 | 330004343 | 1.79 | 62.7 | Neo-adjuvant (N) | null | 2016-11-27 | EURAMOS TRIAL | N | Y | 330011479 | EURAMOS TRIAL |
| 330012728 | 330008375 | 1.78 | null | Palliative (P) | 2018-12-11 | 2018-12-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330011513 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012729 | 330008377 | 1.8 | 80.7 | Curative (C) | 2014-10-16 | 2014-11-20 | Cetuximab + Radiotherapy Maint | N | null | 330011517 | CETUXIMAB + RT |
| 330012730 | 330008378 | 1.83 | null | null | 2014-09-03 | 2014-10-09 | BENDAMUSTINE + RITUXIMAB | N | Y | 330011529 | BENDAMUSTINE + RITUXIMAB |
| 330012731 | 330004367 | 1.62 | 79.4 | Palliative (P) | 2018-12-29 | 2019-07-17 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330011598 | CARBO + FLUOROURACIL |
| 330012732 | 330008382 | 1.7 | 72.4 | Curative (C) | 2018-10-20 | 2018-11-11 | Bendamustine+Rituximab(Sub Courses) | N | Y | 330011603 | BENDAMUSTINE + RITUXIMAB |
| 330012733 | 330004375 | 1.73 | 75.099 | Palliative (P) | 2015-08-03 | 2015-08-03 | CETUXIMAB + RT | 02 | N | 330011654 | CETUXIMAB + RT |
| 330012734 | 330004383 | 1.71 | 64 | Palliative (P) | 2014-12-30 | 2015-01-03 | Paclitaxel (2 or 3 weekly) | N | N | 330011685 | PACLITAXEL |
| 330012735 | 330008395 | null | 65.7 | Palliative (P) | null | 2017-09-07 | VAI (Ifos 3g/m2) | null | null | 330011757 | VAI |
| 330012736 | 330004406 | 1.58 | 47.8 | Palliative (P) | 2014-04-04 | 2014-07-16 | EURAMOS TRIAL | N | N | 330011786 | EURAMOS TRIAL |
| 330012737 | 330004410 | null | 85.85 | Curative (C) | 2015-03-13 | 2015-03-14 | VAI (Ifos 3g/m2) | 02 | N | 330011787 | VAI |
| 330012738 | 330004415 | 1.69 | 75.65 | null | 2017-03-07 | 2017-07-12 | Carbo F | Y | null | 330011813 | CARBO + FLUOROURACIL |
| 330012739 | 330008418 | 1.6 | 68.7 | Curative (C) | null | 2015-02-07 | CARBOPLATIN + FLUOROURACIL | null | null | 330011961 | CARBO + FLUOROURACIL |
| 330012740 | 330004445 | 1.72 | 14.4 | Curative (C) | 2018-05-25 | 2018-10-04 | EURAMOS TRIAL | 2 | N | 330011964 | EURAMOS TRIAL |
| 330012741 | 330004448 | 1.85 | 63.65 | Palliative (P) | 2018-10-14 | 2018-12-24 | Bendamustine+Rituximab(Sub Courses) | N | N | 330011981 | BENDAMUSTINE + RITUXIMAB |
| 330012742 | 330008461 | 1.86 | 78 | Palliative (P) | 2015-10-24 | 2015-11-27 | Bendamustine+Rituximab(Sub Courses) | 02 | Y | 330012305 | BENDAMUSTINE + RITUXIMAB |
| 330012743 | 330004537 | 1 | 35.4 | Palliative (P) | 2018-11-17 | 2019-01-19 | Bendamustine+Rituximab(Sub Courses) | null | null | 330012373 | BENDAMUSTINE + RITUXIMAB |
| 330012744 | 330010588 | 1.73 | 78 | Neo-adjuvant (N) | null | 2017-07-08 | Bendamustine+Rituximab(Sub Courses) | null | null | 330012378 | BENDAMUSTINE + RITUXIMAB |
| 330012745 | 330004541 | 1.76 | 74.9 | Adjuvant (A) | 2018-08-08 | 2018-09-04 | VAI (Ifos 3g/m2) | 02 | Y | 330012379 | VAI |
| 330012746 | 330004549 | 1.73 | 88 | Palliative (P) | 2017-09-27 | 2018-01-04 | Cetuximab + Radiotherapy Maint | N | N | 330012411 | CETUXIMAB + RT |
| 330012747 | 330004579 | 1.8 | 51 | Palliative (P) | 2018-02-09 | 2018-08-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012557 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012749 | 330008510 | 1.8 | 73.65 | Palliative (P) | 2019-10-17 | 2019-10-17 | Carboplatin + Etoposide iv&po | 2 | Y | 330012634 | CARBOPLATIN + ETOPOSIDE |
| 330012750 | 330004640 | null | 90.7 | Curative (C) | null | 2015-03-03 | ALL UKALL2011 Cap Int Maint C PAsp | null | null | 330012805 | UKALL2011 |
| 330012751 | 330004652 | null | 67.4 | Palliative (P) | 2016-07-02 | 2017-06-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012860 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012752 | 330008543 | 1.8 | 54.1 | Palliative (P) | 2018-10-28 | 2018-11-12 | CARBOPLATIN + PACLITAXEL | N | N | 330012935 | CARBOPLATIN + PACLITAXEL |
| 330012753 | 330004675 | null | 123.2 | null | 2017-05-02 | 2017-05-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012987 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012754 | 330004684 | 1.74 | 78.8 | Curative (C) | 2017-05-02 | 2018-09-07 | ALL UKALL2011 Ind A Std Dex (PAsp) | N | N | 330013060 | UKALL2011 |
| 330012755 | 330004711 | 1.58 | 73.9 | Palliative (P) | 2015-08-03 | 2015-09-28 | ALL UKALL2011 Cap Int Maint C PAsp | N | N | 330013142 | UKALL2011 |
| 330012756 | 330012822 | 1.75 | 80.2 | Palliative (P) | 2015-06-29 | 2015-06-29 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330013156 | CARBOPLATIN + PACLITAXEL |
| 330012757 | 330004731 | 1.73 | null | Not known (9) | 2015-08-19 | 2015-08-19 | Paclitaxel (2 or 3 weekly) | 2 | N | 330013234 | PACLITAXEL |
| 330012758 | 330004737 | 1.52 | 64.75 | Palliative (P) | 2018-04-10 | 2018-04-16 | NIVOLUMAB | N | N | 330013247 | AZACITIDINE |
| 330012759 | 330004761 | 0 | 74.9 | Not known (9) | 2017-09-07 | 2017-11-29 | Cyclophosphamide + Topotecan | 02 | N | 330013308 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012760 | 330004782 | 1.77 | 74.9 | Curative (C) | 2018-12-11 | 2018-12-18 | Methotrexate intrathecal | N | N | 330013532 | METHOTREXATE INTRATHECAL |
| 330012762 | 330004800 | 1.57 | 67 | Curative (C) | 2017-03-28 | 2017-04-11 | GemCarbo Days 1+8 | N | null | 330013757 | GEMCARBO |
| 330012763 | 330004814 | 0 | 65.4 | Neo-adjuvant (N) | null | 2018-03-06 | Cyclophosphamide + Topotecan | N | null | 330013921 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012764 | 330008629 | 0 | 98.1 | Palliative (P) | 2017-07-10 | 2017-07-10 | Docetaxel | N | N | 330013942 | DOCETAXEL |
| 330012765 | 330004832 | null | 66 | null | 2015-01-26 | 2015-06-30 | DA 3 + 10 | N | N | 330014044 | VINBLASTINE |
| 330012766 | 330010683 | 1.7 | 112 | Curative (C) | null | 2013-12-21 | Cisplatin + Doxorubicin | 2 | N | 330014135 | CISPLATIN + ETOPOSIDE |
| 330012767 | 330004842 | 1.8 | 64 | Palliative (P) | 2016-04-12 | 2016-04-12 | Cytarabine High Dose | N | N | 330014163 | CYTARABINE HIGH DOSE |
| 330012768 | 330004854 | 1.24 | 8.8 | Curative (C) | null | 2017-01-07 | Liposomal Doxorubicin (Caelyx) | N | N | 330014295 | LIPOSOMAL DOXORUBICIN |
| 330012769 | 330004864 | 0 | null | Palliative (P) | 2015-12-29 | 2016-04-24 | CNS Low Grade Glioma Vinblastine | null | null | 330014435 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012771 | 330010697 | 1.58 | 67 | Palliative (P) | null | 2013-12-19 | EW EuroEwing 99 : VIDE | N | Y | 330014643 | EURO-EWING |
| 330012772 | 330008672 | 1.72 | 65.5 | Curative (C) | 2016-03-02 | 2016-03-26 | Cytarabine High Dose | N | N | 330014715 | CYTARABINE HIGH DOSE |